CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 70 enrolled
Drug / intervention
2% Lidocaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03414359
NCT03414359Early Ph 1Completed

A Randomized, Double-blind Study Comparing 3% Chloroprocaine Versus 2 % Lidocaine/ Epinephrine/ Bicarbonate/ Fentanyl for Epidural Anesthesia in Elective Cesarean Delivery

University of Arkansas·interventional·Posted Jan 29, 2018·Updated Apr 13, 2020

In Brief

A Early Phase 1 clinical trial evaluating 2% Lidocaine and 3% Chloroprocaine for Surgical Anesthesia, Cesarean Section. Completed, enrolled 70 participants across 1 site.

Detailed Summary

Regional anesthesia is commonly used for elective and emergency cesarean delivery. It provides numerous safety advantages when compared to general anesthesia for both the mother and fetus1. Epidurals also have the added benefit of being able to provide pain relief throughout labor and in the event of cesarean delivery, epidural analgesia can be "extended" to provide surgical anesthesia. Numerous studies have been performed to assess the onset times of various local anesthetics when administered through an epidural catheter. Attempts to reduce anesthetic onset time and improve the quality of intraoperative analgesia have been attempted by using different local anesthetic solutions and by the addition of other drugs to the epidural solution (such as epinephrine, fentanyl and sodium bicarbonate).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedJan 29, 2018
Enrollment StartFeb 15, 2018
Primary CompletionMar 27, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 8.4 years ago

Interventions

2% Lidocainedrug

2% Lidocaine using a combined spinal-epidural (CSE)

3% Chloroprocainedrug

3% Chloroprocaine using a combined spinal-epidural (CSE)